SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : EQUIDYNE CORP: IJX (AMEX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dgrebles who wrote (159)7/20/2001 9:05:14 AM
From: Skywatcher   of 179
 
This may lead the way,but major disappointment that the So Cal Company ABT didn't go with IJX

Weston Medical and Abbott Laboratories Announced
Option and Licensing Agreement for Novel Needlefree
Injection Technology

PETERBOROUGH, England, and ABBOTT PARK, Ill., July 20 /PRNewswire/ -- Weston
Medical Group plc (LSE: WMG) and Abbott Laboratories (NYSE: ABT - news)
announced today that they have entered into an exclusive, world-wide option and licensing
agreement for the evaluation of Weston Medical's Intraject® needlefree drug delivery
technology.

Weston and Abbott will conduct joint studies to evaluate the Intraject technology for
potential use with appropriate compounds in Abbott's pharmaceutical pipeline. If Abbott
exercises its option, Abbott would have an exclusive right to utilise the Intraject technology
for up to eleven therapeutic targets throughout the next 10 years. The potential annual peak
sales for clinical candidates that may be appropriate for use with the technology are
estimated to be in excess of 500 million U.S. dollars.

Under the terms of the agreement, Weston Medical would receive upfront fees, milestone
payments and royalties on the combined sales value of the drug plus the Intraject device.
Financial terms of the agreement were not disclosed.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News